FOXO4-DRI is a D-retro-inverso peptide built from a FOXO4 fragment that binds p53, joined to a cell-penetrating sequence, with a molecular weight near 4.8 kDa
By law, any form of bodily introduction of this product into humans or animals is strictly prohibited
Last reviewed: June 22, 2026 Last updated: June 22, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Among these candidates, miR-29b-3p and miR-769-5p showed significantly altered expression in HCC and PCa tissues compared with adjacent non-tumor tissues (Fig
Acknowledgments This work was supported by National Institutes of Health grants R01 AG057381 and R01 AG057381 (Ladiges PI)
It enhances sleep, cognitive performance, skin health, and possibly prevents tumor growth